Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Parodontax (GSK)
- Development stage
- Unknown
- Lead developer
- HALEON
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Parodontax** is a marketed oral-care brand of topical toothpaste and mouthwash products intended for gum health, including control of plaque-associated gingival bleeding and gingivitis. The exact formulation is market- and product-specific: current US OTC Parodontax toothpaste labels identify stannous fluoride as the active anticavity and antigingivitis ingredient, while other Parodontax toothpaste formulations have used high concentrations of sodium bicarbonate to aid plaque removal. The Colgate-Palmolive-sponsored six-month study cited in the record evaluated Parodontax toothpaste as a comparator; it does not establish Colgate-Palmolive as the product developer. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02080273))
- Brand names
- Parodontax
Beyond the preview
Go deeper on Parodontax (GSK).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Parodontax (GSK).